معرفی
Georgios Astras serves as Clinical Associate Professor in the Department of Oncology at the School of Medicine, European University Cyprus. He maintains active clinical roles as Pathologist Oncologist across multiple Cypriot institutions including PMC Nicosia, AMC Nicosia, St. George & Blue Cross Clinic in Paphos, German Oncology Center in Limassol, and Royal Bournemouth Hospital in the UK since 2011.
Academic qualifications:
- MSc in Oncology (Personalized Oncology), University of Newcastle, 2011
- MD in Medicine, Semmelweis University, 2001 (Thesis: Cholinomimetic Treatment in Alzheimer's)
His research focuses on integrating pharmacogenomics into clinical oncology practice, with expertise in liquid biopsy diagnostics for non-invasive cancer monitoring and hepatobiliary surgical interventions. Current investigations include rare oncological conditions such as thyroid paraganglioma and pituitary metastases, emphasizing translational applications of genetic profiling in treatment personalization.
Recent publication trends demonstrate consistent emphasis on practical implementation of pharmacogenomic testing in private practice settings, reflecting industry movement toward genetically-informed therapeutic decision frameworks for cancer management.
Research leadership includes Principal Research Member roles for:
- Pharmacogenomic testing for personalized cancer (OncoDNA & CAPapaellinas, 2018-2020)
- Non-invasive diagnostics via liquid biopsy (NIPD Genetics, 2019-2020)
Professional activities extend to hospital-based clinical teams across Nicosia, Paphos, and Limassol, where he implements research findings in diagnostic pathology and oncological treatment protocols within multidisciplinary cancer care units.
